Prostate Cancer
Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study.
October 19, 2023
Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer.
October 19, 2023
Patient and Context Factors in the Adoption of Active Surveillance for Low-Risk Prostate Cancer.
October 19, 2023
Magnetic Resonance Imaging-Targeted Versus Systematic Prostate Biopsies: 2-year Follow-up of a Prospective Randomized Trial (PRECISE).
October 18, 2023
Radioligand Therapy With 177Lu-PSMA-I&T in Patients With Metastatic Prostate Cancer: Oncological Outcomes and Toxicity Profile.
October 18, 2023
Metastatic prostate cancer is associated with distinct higher frequency of genetic mutations at diagnosis.
October 17, 2023
Cancer Detection Rate and Abnormal Interpretation Rate of Prostate MRI in Patients with Low-grade Cancer.
October 17, 2023
Impact of Prostate Cancer Related Genitourinary Radiation Injury on Mental Health Diagnosis and Treatment: Assessment of 55,425 Men.
October 17, 2023
Prostate cancer image guided radiotherapy: Why the commotion over rectal volume and motion?
October 17, 2023
Relugolix vs. Leuprolide Effects on Castration Resistance-Free Survival from the Phase 3 HERO Study in Men with Advanced Prostate Cancer.
October 17, 2023
Concurrent targeting of HDAC and PI3K to overcome phenotypic heterogeneity of castration-resistant and neuroendocrine prostate cancers.
October 16, 2023
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews.
October 16, 2023